CSMD3
Basic information
Region (hg38): 8:112222928-113436939
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CSMD3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 27 | 14 | 42 | |||
missense | 148 | 13 | 170 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 9 | 8 | 18 | ||
non coding | 2 | |||||
Total | 0 | 0 | 150 | 38 | 27 |
Variants in CSMD3
This is a list of pathogenic ClinVar variants found in the CSMD3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-112224816-C-T | CSMD3-related disorder | Benign (Dec 20, 2019) | ||
8-112224868-G-A | not specified | Uncertain significance (Dec 02, 2021) | ||
8-112228792-A-G | not specified | Uncertain significance (Oct 12, 2021) | ||
8-112228823-T-G | not specified | Uncertain significance (Dec 09, 2023) | ||
8-112228837-C-T | not specified | Uncertain significance (Dec 14, 2021) | ||
8-112228859-T-G | CSMD3-related disorder | Benign (Oct 17, 2019) | ||
8-112231559-C-T | not specified | Uncertain significance (Nov 07, 2022) | ||
8-112234358-T-C | Likely benign (Oct 01, 2023) | |||
8-112234431-A-G | CSMD3-related disorder | Benign (Sep 30, 2019) | ||
8-112234441-C-T | not specified | Likely benign (Jul 20, 2021) | ||
8-112237207-A-C | not specified | Uncertain significance (Oct 27, 2022) | ||
8-112237208-T-C | not specified | Uncertain significance (Sep 06, 2022) | ||
8-112237229-C-T | not specified | Uncertain significance (Feb 09, 2022) | ||
8-112237296-G-T | not specified | Uncertain significance (Mar 19, 2024) | ||
8-112237297-A-G | not specified | Uncertain significance (May 17, 2023) | ||
8-112241725-A-G | CSMD3-related disorder | Benign (Apr 16, 2019) | ||
8-112244433-A-C | not specified | Uncertain significance (Jul 20, 2021) | ||
8-112244475-C-G | not specified | Uncertain significance (Feb 22, 2023) | ||
8-112244519-T-A | not specified | Uncertain significance (Jul 25, 2023) | ||
8-112244549-G-A | not specified | Uncertain significance (Nov 06, 2023) | ||
8-112244557-C-G | not specified | Uncertain significance (Aug 15, 2023) | ||
8-112247099-T-C | CSMD3-related disorder | Likely benign (Feb 25, 2019) | ||
8-112247125-T-C | not specified | Uncertain significance (Nov 08, 2022) | ||
8-112247135-T-C | CSMD3-related disorder | Likely benign (Mar 28, 2019) | ||
8-112254262-G-A | CSMD3-related disorder | Benign (May 31, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CSMD3 | protein_coding | protein_coding | ENST00000297405 | 71 | 1214172 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0571 | 0.943 | 125672 | 0 | 76 | 125748 | 0.000302 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.14 | 1813 | 1.95e+3 | 0.927 | 0.000101 | 24216 |
Missense in Polyphen | 710 | 868.58 | 0.81743 | 10769 | ||
Synonymous | -2.61 | 760 | 674 | 1.13 | 0.0000349 | 7132 |
Loss of Function | 9.96 | 46 | 197 | 0.234 | 0.0000106 | 2374 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000594 | 0.000594 |
Ashkenazi Jewish | 0.000794 | 0.000794 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000300 | 0.000299 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000327 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in dendrite development. {ECO:0000250|UniProtKB:Q80T79}.;
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.585
- rvis_EVS
- -3.49
- rvis_percentile_EVS
- 0.35
Haploinsufficiency Scores
- pHI
- 0.399
- hipred
- Y
- hipred_score
- 0.649
- ghis
- 0.567
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.758
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Csmd3
- Phenotype
Gene ontology
- Biological process
- regulation of dendrite development
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function